Comparison between Greenleaf Envirotech IPO and Invicta Diagnostic IPO.
Greenleaf Envirotech IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Invicta Diagnostic IPO is a SME Bookbuilding proposed to list at NSE SME.
| Greenleaf Envirotech IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Logo | ![]() | ![]() |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Smart Horizon Capital Advisors Pvt.Ltd. | Socradamus Capital Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP ![]() | DRHP ![]() |
| RHP | RHP ![]() | |
| Final Prospectus | Final Prospectus ![]() | Final Prospectus ![]() |
| Anchor Investor | Anchor Investor ![]() | |
| IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Greenleaf Envirotech IPO is up to ₹20.75 Cr whereas the issue size of the Invicta Diagnostic IPO is up to ₹26.71 Cr. The final issue price of Greenleaf Envirotech IPO is ₹136.00 per share and of Invicta Diagnostic IPO is ₹85.00 per share.
| Greenleaf Envirotech IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹85.00 per share | |
| Issue Price (Final) | ₹136.00 per share | ₹85.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1600 shares |
| Fresh Issue Size | 12,26,000 shares | 31,42,400 shares |
| Fresh Issue Size (Amount) | up to ₹16.67 Cr | up to ₹26.71 Cr |
| OFS Issue Size | 3,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹4.08 Cr | up to ₹0.00 Cr |
| Issue Size Total | 15,26,000 shares | 31,42,400 shares |
| Issue Size Total (Amount) | up to ₹20.75 Cr | up to ₹26.71 Cr |
Greenleaf Envirotech IPO opens on Sep 30, 2025, while Invicta Diagnostic IPO opens on Dec 01, 2025. The closing date of Greenleaf Envirotech IPO and Invicta Diagnostic IPO is Oct 06, 2025, and Dec 03, 2025, respectively.
| Greenleaf Envirotech IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Bid Date | Nov 28, 2025 | |
| Issue Open | Sep 30, 2025 | Dec 01, 2025 |
| Issue Close | Oct 06, 2025 | Dec 03, 2025 |
| Basis Of Allotment (Tentative) | Oct 07, 2025 | Dec 04, 2025 |
| Initiation of Refunds (Tentative) | Oct 08, 2025 | Dec 05, 2025 |
| Credit of Share (Tentative) | Oct 08, 2025 | Dec 05, 2025 |
| Listing date (Tentative) | Oct 09, 2025 | Dec 08, 2025 |
| Anchor Lockin End date 1 | Jan 02, 2026 | |
| Anchor Lockin End date 2 | Mar 03, 2026 |
Greenleaf Envirotech IPO P/E ratio is 13.38, as compared to Invicta Diagnostic IPO P/E ratio of 14.51.
| Greenleaf Envirotech IPO | Invicta Diagnostic IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Greenleaf Envirotech Ltd.'s revenue increased by 20% and profit after tax (PAT) rose by 106% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Invicta Diagnostic Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 78.85 | 90.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.37 | 66.69 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.38 | 14.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹80.64 Cr. | ₹106.86 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 46.68% | 44.28% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.01% | 42.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.20 | 0.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.17 | ₹5.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 37.84% | 36.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Greenleaf Envirotech IPO Retail Individual Investors (RII) are offered 7,78,000 shares while in Invicta Diagnostic IPO retail investors are offered 7,78,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Greenleaf Envirotech IPO and 5,34,400 shares in Invicta Diagnostic IPO.
| Greenleaf Envirotech IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 7,98,400 shares |
| Market Maker Reservation | 84,000 shares | 1,66,400 shares |
| QIB | 0 shares | 5,34,400 shares |
| NII | 7,48,000 shares | 5,42,400 shares |
| RII | 7,78,000 shares | 12,67,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 15,26,000 shares | 31,42,400 shares |
Greenleaf Envirotech IPO subscribed 3.84x in total, whereas Invicta Diagnostic IPO subscribed 4.27x.
| Greenleaf Envirotech IPO | Invicta Diagnostic IPO | |
|---|---|---|
| QIB (times) | 3.51x | |
| NII (times) | 4.16x | 6.96x |
| Big NII (times) | 7.30x | |
| Small NII (times) | 6.27x | |
| RII (times) | 3.52x | 3.44x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.84x | 4.27x |